BRKR241220C52500
- 7.30
- 0.000.00%
Bruker Corp Newsroom
Bruker Coverage Assumed by UBS at Neutral Vs Previous Rating of Buy
UBS Downgrades Bruker Corp(BRKR.US) to Hold Rating, Cuts Target Price to $66
UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102
Goldman Sachs Upgrades Bruker Corp(BRKR.US) to Hold Rating
Bruker Price Target Maintained With a $60.00/Share by Goldman Sachs
Bruker Raised to Neutral From Sell by Goldman Sachs
Bruker Analyst Ratings
Bruker Price Target Cut to $69.00/Share From $75.00 by Barclays
Bruker Is Maintained at Overweight by Barclays
Bruker Analyst Ratings
TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Cuts Target Price to $70
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $85
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $69 to $80
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $78
Leerink Partners Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $90
Bruker Price Target Announced at $75.00/Share by Barclays
Bruker Initiated at Overweight by Barclays
Bruker Analyst Ratings
Barclays Initiates Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $75